Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GIGA-564 by GigaGen for Solid Tumor: Likelihood of Approval
GIGA-564 is under clinical development by GigaGen and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...